Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today ...
Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node ...
SLNB surgery is used to determine whether a patient’s melanoma has spread to the lymph node; the procedure has the potential for complications and returns a biopsy that is negative for metastatic ...
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes — a finding that could ...
SAN ANTONIO, Dec. 18 /PRNewswire/ -- Results from a prospective clinical study show that the GeneSearch(TM) Breast Lymph Node (BLN) Assay, a gene-based diagnostic test has greater sensitivity than ...
Outcomes of elderly stage I lung cancer patients treated with segmentectomy via video assisted thoracoscopic surgery or open resection. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
Lymph node dissections, or lymphadenectomies, are surgical procedures that play an important role in cancer treatments. A healthcare professional will remove the lymph nodes and check a tissue sample ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results